Published in Lancet on February 17, 1979
Hypercalcaemia in alphacalcidol therapy. Postgrad Med J (1981) 1.08
Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J (1993) 4.28
Bone disease after jejuno-ileal bypass for obesity. Lancet (1978) 3.84
Abnormal intestinal permeability to sugars in villous atrophy. Lancet (1979) 3.18
Milk consumption and bone mineral density in middle aged and elderly women. BMJ (1994) 2.85
Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk. BMJ (1998) 2.74
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Intestinal permeability in children with Crohn's disease and coeliac disease. Br Med J (Clin Res Ed) (1982) 2.36
Increase in human intestinal permeability following ingestion of hypertonic solutions. J Physiol (1977) 2.04
Comparison between the lengths of individual osteoid seams and resorption cavities in human iliac crest cancellous bone. Bone Miner (1993) 2.03
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr (1981) 1.79
Necrotising lymphadenitis without granulocytic infiltration (Kikuchi's disease). J Clin Pathol (1985) 1.63
Unsuspected tuberculosis in general hospitals. Lancet (1973) 1.55
T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion. Rheumatology (Oxford) (2003) 1.52
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone (2003) 1.51
Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption. Br Med J (1977) 1.48
Bone density: BMC, BMD, or corrected BMD? Bone (1995) 1.47
Gut regulatory peptides and intestinal permeability in acute infantile gastroenteritis. Arch Dis Child (1992) 1.46
Drug therapy for diabetic dyslipoproteinaemia: a practical approach. Diabet Med (1990) 1.42
Guidelines on the management of osteoporosis associated with chronic liver disease. Gut (2002) 1.40
Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers. Br J Radiol (1991) 1.40
Plasma osmolality, iodine concentration and urographic images following high and low osmolar contrast media. Clin Radiol (1991) 1.39
Triglycerides in diabetes: time for action? Diabet Med (1994) 1.38
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ (1993) 1.38
The localization of androgen receptors in human bone. J Clin Endocrinol Metab (1997) 1.37
Mucin depletion in inflammatory bowel disease. J Clin Pathol (1990) 1.36
Estimation of disaccharides in plasma and urine by gas-liquid chromatography. J Chromatogr (1979) 1.36
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest (1982) 1.35
Value of the history in diagnosis of histological osteomalacia among Asians presenting to the NHS. Lancet (1983) 1.33
Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia. J Clin Pathol (1982) 1.29
Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis (1992) 1.29
Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int (2001) 1.27
Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut (1977) 1.26
Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis (2004) 1.25
Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet (1977) 1.25
Mannitol estimation in biological fluids by gas-liquid chromatography of trimethylsilyl derivatives. Clin Chem (1980) 1.25
Enzymatic measurement of choline-containing phospholipids in bile. J Lipid Res (1981) 1.24
Milk feeding and changes in intestinal permeability and morphology in the newborn. J Pediatr Gastroenterol Nutr (1988) 1.24
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int (2010) 1.19
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Osteomalacia after small-intestinal resection. Lancet (1978) 1.16
Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res (1982) 1.16
Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone (1998) 1.14
A prospective study of discordance in diagnosis of osteoporosis using spine and proximal femur bone densitometry. Osteoporos Int (2003) 1.09
Sex hormones and bone mineral density in elderly men. Bone Miner (1993) 1.07
Intestinal permeability changes and excretion of micro-organisms in stools of infants with diarrhoea and vomiting. Arch Dis Child (1985) 1.07
Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med (1991) 1.07
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). Osteoporos Int (2012) 1.07
Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat (1999) 1.07
Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res (1984) 1.06
Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3. Gut (1979) 1.06
Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut (1988) 1.05
Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut (1988) 1.03
Iliac crest trabecular bone mass and structure in patients with non-steroid treated rheumatoid arthritis. Ann Rheum Dis (1987) 1.03
Value of Tru-cut biopsy in the diagnosis of soft tissue tumours. Br J Surg (1986) 1.03
The effect of hyperacetatemia on cardiac output during regular hemodialysis. Clin Nephrol (1982) 1.03
Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut (1986) 1.02
Combined inter-observer and inter-method variation in bone histomorphometry. Bone (1992) 1.01
Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy X-ray absorptiometers. Br J Radiol (1992) 1.01
Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone (2001) 1.01
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int (2013) 1.00
The expression of thyroid hormone receptors in human bone. Bone (1997) 1.00
Differential involvement of the dorsal and lumbar spine in osteoporosis. Ann Rheum Dis (1992) 1.00
Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability. Clin Chem (1990) 1.00
Cardiovascular and acid-base effects of acetate and bicarbonate haemodialysis. Nephrol Dial Transplant (1987) 0.99
Frequency of citation and outcome of cholesterol lowering trials. BMJ (1992) 0.98
A new method for the two-dimensional analysis of bone structure in human iliac crest biopsies. J Microsc (1986) 0.98
Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int (1995) 0.97
Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor, and marrow space star volume. J Bone Miner Res (1996) 0.97
Small bowel function in acute lymphoblastic leukaemia. Arch Dis Child (1984) 0.96
Effects of self monitoring of triglyceride concentrations in non-insulin dependent diabetes. BMJ (1993) 0.96
Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate. Gastroenterology (1983) 0.96
Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone (1998) 0.95
Reduced plasma half-life of radio-labelled 25-hydroxyvitamin D3 in subjects receiving a high-fibre diet. Br J Nutr (1983) 0.95
Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone (2005) 0.95
Serum calcium status in health and disease: a comparison of measured and derived parameters. Clin Chim Acta (1986) 0.94
Diffuse interstitial pulmonary fibrosis complicating Hodgkin's disease. Br J Dis Chest (1977) 0.94
Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol (2000) 0.93
Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption. Gut (1982) 0.93
Simultaneous quantification of mannitol, 3-O-methyl glucose, and lactulose in urine by HPLC with pulsed electrochemical detection, for use in studies of intestinal permeability. Clin Chem (1993) 0.92
Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. Bone (1996) 0.92
Risk factors for nonvertebral fracture in obese older women. J Clin Endocrinol Metab (2011) 0.92
Effect of long term tamoxifen treatment on bone turnover in women with breast cancer. BMJ (1993) 0.92
A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner (1993) 0.92
Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology (Oxford) (2002) 0.91
Age-related changes in trabecular width and spacing in human iliac crest biopsies. Bone Miner (1989) 0.91
Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? Bone (2000) 0.91
Effect of estrogen suppression on the mineralization density of iliac crest biopsies in young women as assessed by backscattered electron imaging. Bone (1998) 0.90
Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone (1996) 0.90
Inter-observer and intra-observer variation in bone histomorphometry. Calcif Tissue Int (1986) 0.90